878197-68-3 Usage
Uses
Used in Pharmaceutical Industry:
5-BROMOIMIDAZO[1,2-A]PYRIDINE-2-CARBALDEHYDE is utilized as a synthetic intermediate for the development of new drugs. Its versatile reactivity allows for the creation of a broad range of pharmaceutical compounds, contributing to the advancement of treatments for various diseases and conditions.
Used in Agrochemical Industry:
In the agrochemical sector, 5-BROMOIMIDAZO[1,2-A]PYRIDINE-2-CARBALDEHYDE is employed as a precursor in the synthesis of novel agrochemicals. Its unique structure and reactivity are harnessed to produce compounds that can enhance crop protection and improve agricultural productivity.
Used in Organic Chemistry Research:
5-BROMOIMIDAZO[1,2-A]PYRIDINE-2-CARBALDEHYDE is also used as a research tool in organic chemistry. Its participation in various organic reactions provides insights into reaction mechanisms and helps in the discovery of new synthetic pathways and methodologies.
Used in the Synthesis of Heterocycles:
Due to its inherent heterocyclic nature, 5-BROMOIMIDAZO[1,2-A]PYRIDINE-2-CARBALDEHYDE is used in the synthesis of other heterocyclic compounds, which are important in various fields such as medicinal chemistry, materials science, and as ligands in coordination chemistry.
Used in the Development of Bioactive Molecules:
5-BROMOIMIDAZO[1,2-A]PYRIDINE-2-CARBALDEHYDE's structural features make it a promising candidate for the development of bioactive molecules with potential applications in biological and medicinal research, including the design of new antibiotics, antivirals, and other therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 878197-68-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,8,1,9 and 7 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 878197-68:
(8*8)+(7*7)+(6*8)+(5*1)+(4*9)+(3*7)+(2*6)+(1*8)=243
243 % 10 = 3
So 878197-68-3 is a valid CAS Registry Number.
878197-68-3Relevant academic research and scientific papers
CXCR4 INHIBITORS AND USES THEREOF
-
Paragraph 00377; 00378, (2018/04/11)
The present invention provides compounds, compositions thereof, and methods of using the same.
Kilogram-scale synthesis of the CXCR4 antagonist GSK812397
Boggs, Sharon,Elitzin, Vassil I.,Gudmundsson, Kristjan,Martin, Michael T.,Sharp, Matthew J.
experimental part, p. 781 - 785 (2010/04/22)
An improved, scalable synthesis of the CXCR4 antagonist GSK812397 is described. This new route was recently scaled up in 50 L fixed equipment to afford 1.2 kg of drug substance in five steps with an overall yield of 20% and >99% chemical and enantiomeric
CHEMICAL COMPOUNDS
-
Page/Page column 49, (2010/11/28)
The present invention provides compounds that demonstrate protective effects on target cells from HIV infection in a manner as to bind to chemokine receptor, and which affect the binding of the natural ligand or chemokine to a receptor such as CXCR4 of a
CHEMICAL COMPOUNDS
-
Page/Page column 41-42, (2008/06/13)
There is provided novel compounds that demonstrate protective effects on target cells from HIV infection in a manner as to bind specifically to the chemokine receptor, and which affect the binding of the natural ligand or chemokine to a receptor such as C
CHEMCIAL COMPOUNDS
-
Page/Page column 54-55, (2010/10/20)
The present invention provides novel compounds that demonstrate protective effects on target cells from HIV infection in a manner as to bind specifically to the chemokine receptor, and which affect the binding of the natural ligand or chemokine to a receptor such as CXCR4 and/or CCR5 of a target cell.
CHEMICAL COMPOUNDS
-
Page/Page column 51, (2010/11/08)
The present invention provides novel compounds that demonstrate protective effects on target cells from HIV infection in a manner as to bind specifically to the chemokine receptor, and which affect the binding of the natural ligand or chemokine to a recep
